Summary & Overview
CPT 92516: Nasopharyngoscopy with Nasal and Facial Nerve Studies
CPT 92516 covers a combined diagnostic evaluation that includes nasopharyngoscopy, nasal functional assessment, and facial nerve testing. Nationally, this code represents an important tool for clinicians in otolaryngology and related specialties to diagnose structural and neuromuscular disorders affecting the nasal passages, nasopharynx, and facial nerve pathways. It is commonly performed in outpatient office settings or independent diagnostic testing facilities and is relevant for a range of clinical presentations involving nasal dysfunction, facial weakness, and related vestibular or auditory symptoms. Key payers considered are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will gain a concise overview of the clinical purpose and service context for CPT 92516, the primary payer landscape, and how this code relates to adjacent otolaryngologic and neurotologic procedures. The publication outlines common coding relationships, typical sites of service, and the clinical scenarios that prompt use of this code. Where specific service-line metadata or payer policy details are not provided, the text flags missing information. This summary is intended to orient clinicians, coding professionals, and policy analysts to the code’s clinical role and the payer mix most likely to be involved in coverage and claims processing.
CPT Code Overview
CPT 92516 is a combined diagnostic procedure encompassing nasopharyngoscopy, nasal study, and facial nerve study. It is categorized under otorhinolaryngologic services and procedures and is used to assess nasal, nasopharyngeal and facial nerve function through endoscopic visualization and functional testing.
This procedure is technically typically performed in an office setting or at an independent diagnostic testing facility (IDTF) where otolaryngology or related clinical services are provided. Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 45-year-old patient presents to an otolaryngology clinic with acute unilateral facial weakness and associated tinnitus. The clinician suspects a facial nerve disorder such as Bell's palsy and requests objective assessment of nasopharyngeal anatomy, nasal airflow, and facial nerve conduction to evaluate possible causes and plan management. The procedure is scheduled in the office or an independent diagnostic testing facility (IDTF). A typical workflow: pre-procedure history and focused cranial nerve exam; application of local topical anesthesia if indicated; performance of nasopharyngoscopy to visualize nasal passages and nasopharynx; nasal airflow study and facial nerve study to record objective nasal and facial nerve function; documentation of findings; technical staff perform equipment setup and recording if componentized billing occurs; professional interpretation and report by the otolaryngologist or neurologist.
Coding Specifications
Modifier 26 - Professional Component:
- Use when billing for the physician’s interpretation and reporting component only.
Modifier TC - Technical Component:
- Use when billing for the technical portion only (equipment, supplies, and technician time) without physician interpretation.
Associated provider taxonomies:
-
207RC0000X- Otolaryngology -
2084N0400X- Neurology
Related Diagnoses
G51.0 - Bell's palsy:
- Acute peripheral facial nerve palsy; directly relevant as
92516includes facial nerve study components to assess nerve function in this condition.
G51.9 - Disorder of facial nerve, unspecified:
- Unspecified facial nerve disorder; facial nerve testing within
92516provides diagnostic information about nerve conduction and function.
R29.810 - Facial weakness:
- Symptom code for facial weakness;
92516evaluates facial nerve function to characterize the deficit.
H93.19 - Tinnitus, unspecified ear:
- Symptom of perceived ear noise; nasal studies may be performed within a broader otorhinolaryngologic assessment that includes
92516when tinnitus accompanies facial or nasal complaints.
H81.90 - Unspecified disorder of vestibular function, unspecified ear:
- Vestibular dysfunction may co-occur with facial nerve or nasal complaints;
92516can be part of a multi-component evaluation when vestibular symptoms are present.
Related CPT Codes
92511 - Nasopharyngoscopy with endoscope:
- Visual endoscopic examination of the nasal passages and nasopharynx. Often performed when more detailed endoscopic visualization is required; may precede or accompany
92516when direct endoscopic inspection is indicated.
92512 - Nasal function studies:
- Objective nasal airflow and function testing.
92512assesses nasal physiology and can overlap or be integrated into the nasal study portion of92516as clinically appropriate.
92520 - Laryngeal function studies:
- Assessment of laryngeal function. Related by shared anatomic region and workflow for head and neck functional testing but addresses laryngeal rather than nasal or facial nerve function; may be ordered in the same visit for concurrent voice complaints.
92540 - Basic vestibular evaluation:
- Screening vestibular testing. May be performed alongside
92516when vestibular symptoms (e.g., dizziness) co-occur with facial nerve or nasal complaints.
92550 - Tympanometry and reflex threshold measurements:
- Middle ear and acoustic reflex testing. Often part of a comprehensive otologic evaluation and may be ordered in conjunction with
92516when ear symptoms such as tinnitus are present.
National Reimbursement Benchmarks
Medicare median and mean rates for 92516 are close to the higher end of the commercial mix: Medicare mean is $78.30 versus the BUCA (representing average commercial) mean of $65.10, placing Medicare above the commercial average by $13.20. UnitedHealth Group and Cigna also report means above Medicare, while Aetna and BCBS report lower mean rates.
Dispersion (P75 minus P25) varies across payers. UnitedHealth Group shows one of the widest spreads at $44.00 (P75 $101.00 minus P25 $57.00), followed by Cigna at $39.67 and BCBS at $29.21. Medicare is among the tightest with a spread of $9.00 (P75 $81.00 minus P25 $72.00), and Aetna is relatively tight with a spread of $14.50. The table and chart below present the full percentile and mean rate breakdown.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.